Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Cayman
Citrullinated LL-37 Monoclonal Antibody (Clone 6A8)
561
CHF
CHF 561.00
In stock
CAY-26739-300300 µgCHF 561.00
Product Details | |
---|---|
Synonyms | Antibacterial Peptide LL-37; Antibacterial Protein LL-37 |
Product Type | Monoclonal Antibody |
Properties | |
Clone | 6A8 |
Isotype | IgG1 |
Immunogen/Antigen | Citrullinated human LL-37 peptide. |
Application | ELISA, WB |
Crossreactivity | Human |
Specificity | Recognizes human citrullinated LL-37. |
Formulation | 300 µg of protein G-purified monoclonal antibody |
Other Product Data |
Click here for Original Manufacturer Product Datasheet |
Declaration | Manufactured by Cayman Chemicals. |
Shipping and Handling | |
Shipping | BLUE ICE |
Long Term Storage | -20°C |
Documents | |
MSDS | Inquire |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
LL-37 is a cationic α-helical peptide expressed in human bone marrow, testis, granulocytes, and gingival epithelium and a variety of immune cells. It has antimicrobial and antiviral activity, and protein levels of LL-37 are increased in epithelial cells, macrophages, and neutrophils following bacterial infection in vitro. LL-37 can be citrullinated by protein arginine deiminase 2 (PAD2) and PAD4, a modification that reduces its antibacterial and antiviral activities. Citrullinated, unlike native, LL-37 does not prevent mortality in a mouse model of D-galactosamine-sensitized endotoxic shock. Citrullinated LL-37 has been found in neutrophil extracellular traps (NETs), as well as the serum of patients with rheumatoid arthritis (RA) and individuals without RA.